TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 45 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $5,998,000 | -3.2% | 6,500,000 | 0.0% | 0.08% | +31.7% |
| Q4 2019 | $6,199,000 | +4.7% | 6,500,000 | 0.0% | 0.06% | -15.5% |
| Q3 2019 | $5,923,000 | -34.2% | 6,500,000 | -35.0% | 0.07% | -47.8% |
| Q3 2017 | $9,006,000 | -15.4% | 10,000,000 | +47.1% | 0.14% | -51.1% |
| Q4 2015 | $10,651,000 | +105.9% | 6,800,000 | +78.9% | 0.28% | +118.9% |
| Q3 2015 | $5,173,000 | -2.9% | 3,800,000 | 0.0% | 0.13% | +29.6% |
| Q2 2015 | $5,330,000 | -5.5% | 3,800,000 | 0.0% | 0.10% | +1.0% |
| Q1 2015 | $5,643,000 | +8.3% | 3,800,000 | 0.0% | 0.10% | +18.3% |
| Q4 2014 | $5,211,000 | +6.9% | 3,800,000 | 0.0% | 0.08% | +90.7% |
| Q3 2014 | $4,876,000 | 0.0% | 3,800,000 | 0.0% | 0.04% | 0.0% |
| Q2 2014 | $4,876,000 | +0.7% | 3,800,000 | 0.0% | 0.04% | +186.7% |
| Q1 2014 | $4,843,000 | +19.5% | 3,800,000 | 0.0% | 0.02% | -63.4% |
| Q4 2013 | $4,054,000 | – | 3,800,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 95,823,000 | $114,365,000 | 5.28% |
| INCOME RESEARCH & MANAGEMENT | 12,056,000 | $14,384,000 | 2.34% |
| AEGON USA Investment Management, LLC | 6,000,000 | $7,159,000 | 1.44% |
| MACKAY SHIELDS LLC | 18,832,000 | $22,547,000 | 1.02% |
| CSS LLC/IL | 14,850,000 | $17,728,000 | 0.86% |
| SHENKMAN CAPITAL MANAGEMENT INC | 8,492,000 | $10,174,000 | 0.78% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,022,000 | $39,393,000 | 0.57% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,088,000 | $7,254,000 | 0.26% |
| AXA S.A. | 34,000,000 | $40,566,000 | 0.18% |
| SSI INVESTMENT MANAGEMENT LLC | 1,664,000 | $1,975,000 | 0.18% |